James M Angelastro

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Cerebral Ischemia

Transcription Factor

Top Venues

Cancer research communications

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lloyd A Greene, Qing Zhou, Markus D Siegelin, James M Angelastro
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. Cells 12 (4) (2023)
Debarshi Banerjee, Shuobo Bobolla, Shunpei Okochi, James M Angelastro, Angela V Kadenhe-Chiweshe, Gonzalo Lopez, Andrea Califano, Eileen P Connolly, Lloyd A Greene, Darrell Yamashiro
Activating Transcription Factor 5 (ATF5) Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer research communications (2023)
Lloyd A Greene, Qing Zhou, Markus D Siegelin, James M Angelastro
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. Cells 12 (4) (2023)
Lloyd A Greene, Qing Zhou, Markus D Siegelin, James M Angelastro
Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. Cells 12 (4) (2023)
Qing Zhou, Xiotian Sun, Nicolas Pasquier, Parvaneh Jefferson, Trang Thi Thu Nguyen, Markus D Siegelin, James M Angelastro, Lloyd A Greene
Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents. Cancers 13 (10) (2021)
Jose A Sandoval, Alexey Tomilov, Sandipan Datta, Sonia Allen, Robert O'Donnell, Thomas Sears, Kevin Woolard, Dmytro Kovalskyy, James M Angelastro, Gino Cortopassi
Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)